These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 21508180

  • 1. Combined administration of quinidine and propafenone for atrial fibrillation: the CAQ-PAF study.
    O'Hara GE, Philippon F, Gilbert M, Champagne J, Michaud V, Charbonneau L, Pruneau G, Hamelin BA, Geelen P, Turgeon J.
    J Clin Pharmacol; 2012 Feb; 52(2):171-9. PubMed ID: 21508180
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerability of oral propafenone versus quinidine in the treatment of recent onset atrial fibrillation: A randomized, prospective study.
    Kosior DA, Kochanowski J, Scisło P, Piatkowski R, Postuła M, Rabczenko D, Opolski G.
    Cardiol J; 2009 Feb; 16(6):521-7. PubMed ID: 19950088
    [Abstract] [Full Text] [Related]

  • 3. Control of paroxysmal atrial fibrillation recurrence using combined administration of propafenone and quinidine.
    Lau CP, Chow MS, Tse HF, Tang MO, Fan C.
    Am J Cardiol; 2000 Dec 15; 86(12):1327-32. PubMed ID: 11113407
    [Abstract] [Full Text] [Related]

  • 4. Is newer better? Propafenone versus quinidine for conversion of atrial fibrillation.
    Daubert JP.
    Cardiol J; 2009 Dec 15; 16(6):491-2. PubMed ID: 19950083
    [No Abstract] [Full Text] [Related]

  • 5. [A comparison between propafenone and hydroquinidine perorally in the treatment of recent-onset atrial fibrillation].
    Satullo G, Arrigo F, Cavallaro L, Coglitore A, Fazio F, Saporito F, Sorrenti S, Oreto G.
    Minerva Cardioangiol; 1996 Mar 15; 44(3):141-4. PubMed ID: 8767614
    [Abstract] [Full Text] [Related]

  • 6. Safety of oral propafenone in the conversion of recent onset atrial fibrillation to sinus rhythm: a prospective parallel placebo-controlled multicentre study.
    Capucci A, Villani GQ, Aschieri D, Piepoli M.
    Int J Cardiol; 1999 Feb 28; 68(2):187-96. PubMed ID: 10189007
    [Abstract] [Full Text] [Related]

  • 7. A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm.
    Capucci A, Boriani G, Rubino I, Della Casa S, Sanguinetti M, Magnani B.
    Int J Cardiol; 1994 Mar 01; 43(3):305-13. PubMed ID: 8181888
    [Abstract] [Full Text] [Related]

  • 8. Comparisons of oral propafenone and quinidine as an initial treatment option in patients with symptomatic paroxysmal atrial fibrillation: a double-blind, randomized trial.
    Lee SH, Chen SA, Chiang CE, Tai CT, Wen ZC, Wang SP, Chang MS.
    J Intern Med; 1996 Mar 01; 239(3):253-60. PubMed ID: 8772625
    [Abstract] [Full Text] [Related]

  • 9. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study.
    Bianconi L, Mennuni M, Lukic V, Castro A, Chieffi M, Santini M.
    J Am Coll Cardiol; 1996 Sep 01; 28(3):700-6. PubMed ID: 8772759
    [Abstract] [Full Text] [Related]

  • 10. [Propafenone versus hydroquinidine in long-term pharmacological prophylaxis of atrial fibrillation].
    Richiardi E, Gaita F, Greco C, Gaschino G, Comba Costa G, Rosettani E, Brusca A.
    Cardiologia; 1992 Feb 01; 37(2):123-7. PubMed ID: 1600529
    [Abstract] [Full Text] [Related]

  • 11. The influence of CYP2D6 polymorphism on the antiarrhythmic efficacy of propafenone in patients with paroxysmal atrial fibrillation during 3 months propafenone prophylactic treatment.
    Jazwinska-Tarnawska E, Orzechowska-Juzwenko K, Niewinski P, Rzemislawska Z, Loboz-Grudzien K, Dmochowska-Perz M, Slawin J.
    Int J Clin Pharmacol Ther; 2001 Jul 01; 39(7):288-92. PubMed ID: 11471772
    [Abstract] [Full Text] [Related]

  • 12. Oral propafenone for rapid conversion of recent onset atrial fibrillation--a review.
    Hughes C, Sunderji R, Gin K.
    Can J Cardiol; 1997 Sep 01; 13(9):839-42. PubMed ID: 9343033
    [Abstract] [Full Text] [Related]

  • 13. Propafenone for the prevention of atrial tachyarrhythmias after cardiac surgery: a randomized, double-blind placebo-controlled trial.
    Mörike K, Kivistö KT, Schaeffeler E, Jägle C, Igel S, Drescher S, Fux R, Marx C, Hofmann U, Engel C, Wagner F, Delabar U, Meisner C, Bail D, Böhm JO, Gleiter CH, Ziemer G, Rein JG, Hellberg KD, Eichelbaum M, Schwab M.
    Clin Pharmacol Ther; 2008 Jul 01; 84(1):104-10. PubMed ID: 18167502
    [Abstract] [Full Text] [Related]

  • 14. Intravenous versus oral initial load of propafenone for conversion of recent-onset atrial fibrillation in the emergency room: a randomized trial.
    Madonia S, De Simone M, Brai G, Gozzo D, Gristina A, Luciano L, Maisano S, Migliore G, Mineo R, Muzzo MP, Nicchi F, Randazzo A, Raspanti G, Rotolo G, Russo A, Sagona F, Schirosa M, Spinello M, Stancampiano R, Geraci E.
    Ital Heart J; 2000 Jul 01; 1(7):475-9. PubMed ID: 10933330
    [Abstract] [Full Text] [Related]

  • 15. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
    Chiladakis JA, Kalogeropoulos A, Patsouras N, Manolis AS.
    J Am Coll Cardiol; 2004 Aug 18; 44(4):859-63. PubMed ID: 15312872
    [Abstract] [Full Text] [Related]

  • 16. Intravenous propafenone in paroxysmal atrial fibrillation: a randomized, placebo-controlled, double-blind, multicenter clinical trial. Paroxysmal Atrial Fibrillation Italian Trial (PAFIT)-2 Investigators.
    Fresco C, Proclemer A, Pavan A, Buia G, Vicentini A, Pavan D, Morgera T.
    Clin Cardiol; 1996 May 18; 19(5):409-12. PubMed ID: 8723601
    [Abstract] [Full Text] [Related]

  • 17. [Propafenone and sotalol: long-term efficacy and tolerability in the prevention of paroxysmal atrial fibrillation. A placebo-controlled double-blind study].
    Bellandi F, Dabizzi RP, Niccoli L, Cantini F, Palchetti R.
    G Ital Cardiol; 1996 Apr 18; 26(4):379-90. PubMed ID: 8707022
    [Abstract] [Full Text] [Related]

  • 18. Quinidine versus propafenone for conversion of atrial fibrillation to sinus rhythm.
    Di Benedetto S.
    Am J Cardiol; 1997 Aug 15; 80(4):518-9. PubMed ID: 9285671
    [Abstract] [Full Text] [Related]

  • 19. [Conversion rate and prevention of recurrence of paroxysmal and sustained atrial fibrillation or atrial flutter with verapamil/quinidine].
    Trappe HJ, Pfitzner P.
    Med Klin (Munich); 1996 Oct 15; 91(10):617-25. PubMed ID: 9019638
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of novel atrial-selective antiarrhythmic agent vernakalant hydrochloride injection (RSD1235): influence of CYP2D6 expression and other factors.
    Mao ZL, Wheeler JJ, Clohs L, Beatch GN, Keirns J.
    J Clin Pharmacol; 2009 Jan 15; 49(1):17-29. PubMed ID: 18927241
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.